Vericel Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vericel Corp with three other
companies in this sector in the United States:
Acceleron Pharma Inc
sales of $27.77 million
Apollo Endosurgery Inc
of which 50%
was Surgical), and
of which 100%
was Cosmetic Products).
Vericel Corp reported sales of $54.38 million
December of 2016.
increase of 6.3%
versus 2015, when the company's sales were $51.17 million.
This was the third consecutive year of growth at Vericel Corp.